Residual disability develops in 50–80% of patients, with transverse myelitis at onset being the most significant predictor of long-term outcome.
MOG antibody disease
Selective immunoglobulin A deficiency
Hyperimmunoglobulin E syndrome
Alagille syndrome
Rh disease
Inborn errors of immunity
Chronic granulomatous disease
Wiskott–Aldrich syndrome